title: Four birds with one stone? Reparative, neuroplastic, cardiorespiratory, and metabolic benefits of aerobic exercise poststroke.
abstract: Converging evidence from animal models of stroke and clinical trials suggests that aerobic exercise has effects across multiple targets.
  
  
  
  The subacute phase is characterized by a period of heightened neuroplasticity when aerobic exercise has the potential to optimize recovery. In animals, low intensity aerobic exercise shrinks lesion size and reduces cell death and inflammation, beginning 24 h poststroke. Also in animals, aerobic exercise upregulates brain-derived neurotrophic factor near the lesion and improves learning. In terms of neuroplastic effects, clinical trial results are less convincing and have only examined effects in chronic stroke. Stroke patients demonstrate cardiorespiratory fitness levels below the threshold required to carry out daily activities. This may contribute to a 'neurorehabilitation ceiling' that limits capacity to practice at a high enough frequency and intensity to promote recovery. Aerobic exercise when delivered 2-5 days per week at moderate to high intensity beginning as early as 5 days poststroke improves cardiorespiratory fitness, dyslipidemia, and glucose tolerance.
  
  
  
  Based on the evidence discussed and applying principles of periodization commonly used to prepare athletes for competition, we have created a model of aerobic training in subacute stroke in which training is delivered in density blocks (duration × intensity) matched to recovery phases.
authors.affiliation: Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada.
authors.forename: Michelle
authors.initials: M
authors.lastname: Ploughman
authors.forename: Liam P
authors.initials: LP
authors.lastname: Kelly
mesh_terms: D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D000072599:Cardiorespiratory Fitness / Q000502:physiology*; D004195:Disease Models, Animal; D015444:Exercise / Q000502:physiology; D005081:Exercise Therapy / Q000379:methods*; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology*; D020521:Stroke / Q000378:metabolism / Q000503:physiopathology*; D000071939:Stroke Rehabilitation; D016896:Treatment Outcome
chemical_list: D019208:Brain-Derived Neurotrophic Factor; C579455:BDNF protein, human